Reckon Biotech-B (02179.HK) has received approval from the China Securities Regulatory Commission for the targeted issuance of domestic shares.

Wise Finance News APP, Ruike Biology-B (02179.HK) announced that on July 23, 2025, the company received the approval from the China Securities Regulatory Commission for the registration of the issuance of shares to specific objects by Jiangsu Ruike Biotechnology Co., Ltd. (Approval No. 1506 [2025]). The China Securities Regulatory Commission has approved the issuance.